AKAaron J. Katz

Aaron J. Katz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Aaron J. Katz has a total of 65 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Financial Toxicity Among Long-Term Prostate Cancer Survivors—Results From a Population-Based Cohort

    by Rahul D. Mali, Katelyn Kane, Ying Cao, Aaron J. Katz, Deborah S. Usinger, Ronald C. Chen, Xinglei Shen

  • Open Access

    Logistic Model in Clinical and Health Research—the Elephant and Blind Men

    by Ying Cao, Aaron J. Katz, Xinglei Shen, Ryan T. Morse, Christopher E. Lominska, Ronald C. Chen

    Logistic models are everywhere in scientific research, including clinical and health research. However, there is no practical report on research results that will utilize many available statistical tools but mostly 1 or 2 only, for a logistic model. We introduce 6 powerful statistical tools, forest plot, AUC curve, nomogram, and decision curve analysis, as well as bootstrapping sampling and cross validation, by applying head and neck cancer data to a logistic model. We hope that these tools will make the logistic model, and accordingly our research, more comprehensive and clinically more applicable. In the 6 parts of the article, we introduce each of the 6 statistical tools (methods) with relevant figures and interpretations on key statistical concepts to show how we can improve our understanding on the logistic model and the clinical prospects behind the data. The statistical tools we present in the current special communication for reporting research or clinical trials in a logistic model, if popularized among researchers and clinicians, will make a research conclusion more comprehensive, valid and clinically applicable to other cases.

  • Open Access

    Prostate Cancer Survivors' Long-Term Supportive Care Needs: Results From a Population-Based Cohort

    by Yahui Xie, Ying Cao, Aaron J. Katz, Rahul D. Mali, Deborah S. Usinger, Xinglei Shen, Ronald C. Chen

    Background: Although there are more than 3.5 million prostate cancer survivors in the United States, unmet needs in this population have not been fully characterized. In a population-based, prospective cohort of prostate cancer survivors, we assessed unmet needs in long-term survivors and whether racial disparities exist. Methods: The North Carolina Prostate Cancer Comparative Effectiveness & Survivorship Study is an observational cohort that enrolled patients with newly diagnosed prostate cancer throughout North Carolina from 2011 to 2013, in collaboration with the state's cancer registry, and followed these patients prospectively with patient-reported data, medical records, and cancer registry data. A total of 645 Black and White participants completed the validated Cancer Survivors' Unmet Needs (CaSUN) survey at 7 to 10 years after treatment. Results: A total of 29.4% of prostate cancer survivors indicated at least 1 unmet need. Three most common unmet needs (related to sex life, financial support, and coordination of care) were each indicated by more than 11% of the cohort. Across all 35 CaSUN need items, a higher proportion of Black vs White prostate cancer survivors indicated an unmet need; in 24 (69%) items, this difference was statistically significant. Multivariable logistic regression showed that Black race (OR 1.73, P = .03) and younger age (OR .96/y, P = .02) were associated with increased odds of having an unmet need. Conclusions: A sizable portion of long-term prostate cancer survivors have at least 1 unmet need, and racial disparities exist. This study demonstrates that significant opportunities exist to identify, understand, and better address the needs of long-term cancer survivors.


  • Open Access

    Posttreatment surveillance intensity and overall survival in prostate cancer survivors (AFT-30)

    by Ronald C Chen, Ramsankar Basak, Stacie Dusetzina, Deborah S Usinger, Zahed Mohammed, Aaron D Falchook, Jessica R Schumacher, Amanda B Francescatti, Amanda Cuddy, George J Chang, et al.

    Post-treatment surveillance affects millions of cancer survivors, but empiric data to guide clinical practice is lacking. This study assessed whether the intensity of surveillance testing after radical prostatectomy (RP) or radiation therapy (RT) for localized prostate cancer is associated with overall survival. Men diagnosed with localized prostate cancer between 2005 and 2010 who underwent RP or RT at a Commission on Cancer-accredited facility were randomly sampled. Primary data collected of 10,147 patients sampled across 1007 facilities were linked with existing data from the National Cancer Database. Analysis examined whether intensity of surveillance measured as the number of PSA tests in the first year after primary treatment [categorized as 0-1 (low intensity), 2 (medium) or ≥ 3 (high intensity) PSA tests] was associated with overall survival. Secondary outcomes included recurrence-free survival (RFS) and subsequent use of imaging tests, biopsy procedures, and salvage treatment. Median follow-up exceeded 8 years from prostate cancer diagnosis. OS was not statistically significantly different across surveillance intensity groups among RT (P = .59) or RP (P = .29) patients. RFS was not statistically significantly different across surveillance intensity groups for RT (P = .13) patients, but was for RP (P = .01) patients with high intensity associated with the worse RFS. In both treatments, higher surveillance intensity was associated with more procedures and salvage treatments. In patients with localized prostate cancer, more frequent PSA surveillance testing after radical prostatectomy or radiation therapy was associated with increased procedures and salvage treatments but not overall survival.


  • Differences in Rural Versus Urban Patients With Prostate Cancer in Diagnosis and Treatment: An Analysis of a Population-Based Cohort

    by Xinglei Shen, Katelyn Kane, Aaron J. Katz, Deborah Usinger, Ying Cao, Ronald C. Chen

    PURPOSE: Patients living in rural communities have greater barriers to cancer care and poorer outcomes. We hypothesized that rural patients with prostate cancer have less access and receive different treatments compared with urban patients. METHODS: We used a population-based prospective cohort, the North Carolina Prostate Cancer Comparative Effectiveness and Survivorship Study, to compare differences in prostate cancer diagnosis, access to care, and treatment in patients by geographic residence. The 2013 rural-urban continuum code (RUCC) was used to determine urban (RUCC 1-3) versus rural (RUCC 4-9) location of residence. RESULTS: Patients with rural residence comprised 25% of the cohort (364 of 1,444); they were less likely to be White race and had lower income and educational attainment. Rural patients were more likely to have <12 cores on biopsy (47.1% v 35.7%; P < .001) and less likely (40.8% v 47.6%; P = .04) to receive multidisciplinary consultation. We observed significant differences in treatment between urban and rural patients, including rural patients receiving less active surveillance or observation (22.6% v 28.7%), especially in low-risk cancer (33.2% v 40.7%). On multivariable analysis that adjusted for patient and diagnostic factors, rural residence was associated with less use of active surveillance or observation over radical treatment (ie, surgery or radiation therapy; odds ratio, 0.49 v urban; P < .001) in patients with low-risk cancer. CONCLUSION: Patients with prostate cancer who live in rural versus urban areas experience several differences in care that are likely clinically meaningful, including fewer cores in the diagnostic biopsy, less utilization of multidisciplinary consultation, less use of active surveillance, or observation for low-risk disease. Future studies are needed to assess the efficacy of interventions in mitigating these disparities.


  • Open Access

    Long-Term Trends in Decisional Regret Among Men with Localized Prostate Cancer

    by Alexandria Alverdy Spellman, Vishnukamal Golla, Li Lin, Aaron Katz, Ronald C. Chen, Leah L. Zullig

    Purpose: There are several evidence-based treatment options for localized prostate cancer (PCa). Decisional regret (DR), or regret based on the treatment a patient chooses, is poorly understood in patients with PCa. We describe long-term trends in DR for patients with localized PCa and factors associated with regret. Materials and Methods: We surveyed an established prospective cohort of patients with PCa in North Carolina who were diagnosed between 2011 and 2013. DR was assessed by a validated instrument at 12, 24, 36, 48, 60, 72, 84, and 120 months after treatment or active surveillance (AS). We estimated the overall trend of DR and examined how DR was associated with treatment and demographic data using generalized linear mixed-model regressions. Results: The sample included 1456 men. At 12 months, 88% (n = 1100) of patients did not regret their treatment. With all time points included, DR increased slightly in early months and the speed of increase slowed over time (P = .003 for time, .02 for time-squared). Divorced men were more likely to have DR compared with married men (odds ratio [OR] = 1.5; 95% confidence interval [CI] 0.9-2.7). African Americans (OR = 1.5; 95% CI 1.0-2.1) and those who underwent surgery had significantly more regret (14.6%; 95% CI 11.3-18.0, P = .01) than patients of other racial groups or who underwent AS, respectively. Conclusions: Although DR is low overall in this cohort, being married and AS were associated with lower regret than those who were not married or who underwent surgery, respectively. Understanding factors that affect DR can guide urologists to more effectively direct resources and counseling.


  • Top Cited Papers

    Geomorphic context in process‐based river restoration

    by Ellen Wohl, Sara Rathburn, Sarah Dunn, Emily Iskin, Aaron Katz, Anna Marshall, Mickey Means‐Brous, Julianne Scamardo, Shayla Triantafillou, Hiromi Uno

    Process‐based river restoration seeks to restore processes such as channel‐floodplain connectivity that create and maintain river corridor functions. Process‐based restoration can fail to produce the desired results if geomorphic context is not effectively incorporated into restoration design. Geomorphic context of a river reach refers to the controls on contemporary river form and process. Controls at the catchment‐ to reach‐scale include geologic history, biophysical characteristics, legacies of past human alterations, position within the river network, river corridor geometry, base level stability, disturbance regime, and contemporary human alterations of the river corridor. We conceptualize a river corridor as reflecting the interactions among fluxes of material and the geomorphic context. We discuss how an understanding of geomorphic context can be used to select a restoration approach and provide examples of how restoration can fail to achieve desired outcomes when geomorphic context is not considered. Within the toolbox of methods used to implement process‐based restoration, we differentiate the alteration of inputs to the river corridor and fluxes of material through the corridor from alteration of form and/or connectivity within the river corridor. Historical, biotic, geologic/geomorphic, and reference sites can be used to inform process‐based restoration targets. Restoration is strongly influenced by human perceptions of what is appropriate and achievable at a site and diverse communities influencing restoration at a site may differ in their perceptions. Geomorphically based conceptual guidelines, such as the River Styles Framework, provide an effective platform for incorporating an understanding of geomorphic context into process‐based river restoration.


  • Open Access

    Telehealth use and perceptions among prostate cancer survivors

    by Luke W. Chen, Deborah S. Usinger, Aaron J. Katz

    Background: Reasons underlying disparities in telehealth use among cancer survivors are unknown.Methods: We surveyed a sociodemographically diverse population‐based cohort of 487 prostate cancer survivors regarding their use and perceptions of telehealth during the COVID‐19 pandemic.Results: Overall, only 28.5% of survivors had used telehealth at the time of survey and just 10% felt care through telehealth is comparable to that of an in‐person visit. Still, over 55% felt telehealth is a good option for initial consultations or basic care and 15% felt more likely to use telehealth since the pandemic. After adjusting for other socioeconomic factors, survivors with lower education (≤high school vs. any college) had marginally lower use of telehealth (risk ratio [RR], 0.65 [95% CI, 0.42–1.01]) and lower probability of feeling more likely to use telehealth since the pandemic (RR, 0.39 [95% CI, 0.20–0.77]).Conclusions: Differences in survivor perceptions of telehealth by education level highlight new insights underlying disparities in telehealth use and potential targets for interventions.